News

Medical Marketing & Media2h
Rx Rundown: Sarep­ta Ther­a­peu­tics, Juul, Pfizer and more
Sino Biopharma will acquire LaNova Medicines, which has licensed cancer drugs for Merck and AstraZeneca, for $951 million.
decrypt13h
GSR Leads $100M Private Placement into Nasdaq-listed MEI Pharma to Launch First Institutional Litecoin Treasury Strategy Alongside Charlie Lee
GSR, crypto's capital markets partner, today announced an investment and strategic partnership with MEI Pharma, Inc.
Fierce Pharma23h
Leo Pharma's slow response to app lapse scolded by UK marketing watchdog
Leo Pharma’s inaccurate Innohep app has prompted a slap-down from the PMCPA. The U.K. | Leo Pharma’s inaccurate Innohep app ...